Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.

MLA

Simon, James A., et al. “Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.” Journal of Women’s Health (2002), vol. 27, no. 1, Jan. 2018, pp. 14–23. EBSCOhost, https://doi.org/10.1089/jwh.2017.6385.

APA

Simon, J. A., Altomare, C., Cort, S., Jiang, W., & Pinkerton, J. V. (2018). Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials. Journal of Women’s Health (2002), 27(1), 14–23. https://doi.org/10.1089/jwh.2017.6385

Chicago

Simon, James A, Corrado Altomare, Susannah Cort, Wei Jiang, and JoAnn V Pinkerton. 2018. “Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.” Journal of Women’s Health (2002) 27 (1): 14–23. doi:10.1089/jwh.2017.6385.